Cargando…
IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy
Statins are effective lipid-lowering drugs with a good safety profile that have become, over the years, the first-line therapy for patients with dyslipidemia and a real cornerstone of cardiovascular (CV) preventive therapy. Thanks to both cholesterol-related and “pleiotropic” effects, statins have a...
Autores principales: | Liberale, Luca, Carbone, Federico, Camici, Giovanni G., Montecucco, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912287/ https://www.ncbi.nlm.nih.gov/pubmed/31652822 http://dx.doi.org/10.3390/jcm8111764 |
Ejemplares similares
-
Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
por: Liberale, Luca, et al.
Publicado: (2021) -
T-cells in myocardial infarction: Culprit instigators or mere effectors?
por: Liberale, Luca, et al.
Publicado: (2018) -
Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
por: Carbone, Federico, et al.
Publicado: (2022) -
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions
por: Tirandi, Amedeo, et al.
Publicado: (2021) -
Sirtuin 1 in Endothelial Dysfunction and Cardiovascular Aging
por: Ministrini, Stefano, et al.
Publicado: (2021)